Evidence map›Paper›PMID 35142027›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2022

Trans-seeding of Alzheimer-related tau protein by a yeast prion.

Martin Flach, Cedric Leu, Alfonso Martinisi, Zhiva Skachokova, Stephan Frank, Markus Tolnay, Henning Stahlberg, David T Winkler

Open access · hybridAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Trans-seeding of Alzheimer-related tau protein by a yeast prion.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Martin FlachInstitute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Cedric LeuCenter for Cellular Imaging and NanoAnalytics (C-CINA), Biozentrum, University of Basel, Basel, Switzerland.
Alfonso MartinisiInstitute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Zhiva SkachokovaInstitute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Stephan FrankInstitute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Markus TolnayInstitute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Henning StahlbergCenter for Cellular Imaging and NanoAnalytics (C-CINA), Biozentrum, University of Basel, Basel, Switzerland.
David T WinklerInstitute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
University Hospital of Basel · CHUniversity of Basel · CHKantonsspital Baselland · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abnormal tau protein aggregates constitute a hallmark of Alzheimer's disease. The mechanisms underlying the initiation of tau aggregation in sporadic neurodegeneration remain unclear. Here we investigate whether a non-human prion can seed tau aggregation. Due to their structural similarity with tau aggregates, we chose Sup35NM yeast prion domain fibrils for explorative tau seedings. Upon in vitro incubation with tau monomers, Sup35NM fibrils promoted the formation of morphologically distinct tau fibril strains. In vivo, intrahippocampal inoculation of Sup35NM fibrils accentuated tau pathology in P301S tau transgenic mice. Thus, our results provide first in vivo evidence for heterotypic cross-species seeding of a neurodegenerative human prion-like protein by a yeast prion. This opens up the conceptual perspective that non-mammalian prions present in the human microbiome could be involved in the initiation of protein misfolding in neurodegenerative disorders, a mechanism for which we propose the term "trans-seeding."

Indexed as

Alzheimer DiseasePrionsTauopathiesAnimalsHumansMiceMice, TransgenicSaccharomyces cerevisiaetau ProteinsPrionstau ProteinsAlzheimer's diseaseneurodegenerationprionseedingSup35tautrans-seedingyeast

Identifiers

PMID35142027
PMCPMC10078693
OpenAlexW4211134828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.